176 related articles for article (PubMed ID: 27336583)
41. Synthesis and antibacterial evaluation of rhodanine-based 5-aryloxy pyrazoles against selected methicillin resistant and quinolone-resistant Staphylococcus aureus (MRSA and QRSA).
Song MX; Zheng CJ; Deng XQ; Sun LP; Wu Y; Hong L; Li YJ; Liu Y; Wei ZY; Jin MJ; Piao HR
Eur J Med Chem; 2013 Feb; 60():376-85. PubMed ID: 23314051
[TBL] [Abstract][Full Text] [Related]
42. Enhanced activity of rifalazil in combination with levofloxacin, linezolid, or mupirocin against Staphylococcus aureus in vitro.
Osburne MS; Murphy CK; Rothstein DM
J Antibiot (Tokyo); 2006 May; 59(5):303-8. PubMed ID: 16883781
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and antibacterial activity of novel 1,3-diphenyl-1H-pyrazoles functionalized with phenylalanine-derived rhodanines.
Zheng CJ; Xu LL; Sun LP; Miao J; Piao HR
Eur J Med Chem; 2012 Dec; 58():112-6. PubMed ID: 23123727
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and biological activity of some derivatives of rifamycin P.
Cavalleri B; Turconi M; Tamborini G; Occelli E; Cietto G; Pallanza R; Scotti R; Berti M; Romanó G; Parenti F
J Med Chem; 1990 May; 33(5):1470-6. PubMed ID: 2329569
[TBL] [Abstract][Full Text] [Related]
45. 3,4-Dihydropyrimidinone-coumarin analogues as a new class of selective agent against S. aureus: Synthesis, biological evaluation and molecular modelling study.
Naik NS; Shastri LA; Joshi SD; Dixit SR; Chougala BM; Samundeeswari S; Holiyachi M; Shaikh F; Madar J; Kulkarni R; Sunagar V
Bioorg Med Chem; 2017 Feb; 25(4):1413-1422. PubMed ID: 28094219
[TBL] [Abstract][Full Text] [Related]
46. Identification of novel 2-aminothiazole conjugated nitrofuran as antitubercular and antibacterial agents.
Ran K; Gao C; Deng H; Lei Q; You X; Wang N; Shi Y; Liu Z; Wei W; Peng C; Xiong L; Xiao K; Yu L
Bioorg Med Chem Lett; 2016 Aug; 26(15):3669-74. PubMed ID: 27289321
[TBL] [Abstract][Full Text] [Related]
47. Rox, a Rifamycin Resistance Enzyme with an Unprecedented Mechanism of Action.
Koteva K; Cox G; Kelso JK; Surette MD; Zubyk HL; Ejim L; Stogios P; Savchenko A; Sørensen D; Wright GD
Cell Chem Biol; 2018 Apr; 25(4):403-412.e5. PubMed ID: 29398560
[TBL] [Abstract][Full Text] [Related]
48. Bisphosphonated benzoxazinorifamycin prodrugs for the prevention and treatment of osteomyelitis.
Reddy R; Dietrich E; Lafontaine Y; Houghton TJ; Belanger O; Dubois A; Arhin FF; Sarmiento I; Fadhil I; Laquerre K; Ostiguy V; Lehoux D; Moeck G; Parr TR; Rafai Far A
ChemMedChem; 2008 Dec; 3(12):1863-8. PubMed ID: 18973169
[No Abstract] [Full Text] [Related]
49. [Tympanostomy tube otorrhea: microbiological epidemiology, pathogen susceptibility to local antibiotics and bactericidal power of the rifamycin-olfloxacin combination].
François M; Mariani-Kurkdjian P; Doit C; Benzekri P; Bingen E; Macé JG
Ann Otolaryngol Chir Cervicofac; 2001 Oct; 118(5):278-82. PubMed ID: 11845035
[TBL] [Abstract][Full Text] [Related]
50. Unraveling the structure-activity relationship of tomatidine, a steroid alkaloid with unique antibiotic properties against persistent forms of Staphylococcus aureus.
Chagnon F; Guay I; Bonin MA; Mitchell G; Bouarab K; Malouin F; Marsault É
Eur J Med Chem; 2014 Jun; 80():605-20. PubMed ID: 24877760
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and antibacterial activity of new symmetric polyoxygenated dibenzofurans.
Oramas-Royo S; Pantoja KD; Amesty Á; Romero C; Lorenzo-Castrillejo I; Machín F; Estévez-Braun A
Eur J Med Chem; 2017 Dec; 141():178-187. PubMed ID: 29031065
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and antibacterial activity of novel modified 5-O-desosamine ketolides.
Chen X; Xu P; Xu Y; Liu L; Liu Y; Zhu D; Lei P
Bioorg Med Chem Lett; 2012 Dec; 22(24):7402-5. PubMed ID: 23122862
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and biological evaluation of 2-mercapto-1,3-benzothiazole derivatives with potential antimicrobial activity.
Franchini C; Muraglia M; Corbo F; Florio MA; Di Mola A; Rosato A; Matucci R; Nesi M; van Bambeke F; Vitali C
Arch Pharm (Weinheim); 2009 Oct; 342(10):605-13. PubMed ID: 19753564
[TBL] [Abstract][Full Text] [Related]
54. Discovery and characterization of aryl isonitriles as a new class of compounds versus methicillin- and vancomycin-resistant Staphylococcus aureus.
Davis DC; Mohammad H; Kyei-Baffour K; Younis W; Creemer CN; Seleem MN; Dai M
Eur J Med Chem; 2015 Aug; 101():384-90. PubMed ID: 26164843
[TBL] [Abstract][Full Text] [Related]
55. Rifamycin-mode of action, resistance, and biosynthesis.
Floss HG; Yu TW
Chem Rev; 2005 Feb; 105(2):621-32. PubMed ID: 15700959
[No Abstract] [Full Text] [Related]
56. Spin-labeled rifamycin: biological activity.
Raykov ZZ; Vassilev K; Grigorova G; Lyapova A; Alexiev A; Petrov G
Pharmazie; 2008 Jan; 63(1):61-6. PubMed ID: 18271306
[TBL] [Abstract][Full Text] [Related]
57. The synthesis and antibacterial activity of pyrazole-fused tricyclic diterpene derivatives.
Yu LG; Ni TF; Gao W; He Y; Wang YY; Cui HW; Yang CG; Qiu WW
Eur J Med Chem; 2015 Jan; 90():10-20. PubMed ID: 25461307
[TBL] [Abstract][Full Text] [Related]
58. Novel promising linezolid analogues: rational design, synthesis and biological evaluation.
De Rosa M; Zanfardino A; Notomista E; Wichelhaus TA; Saturnino C; Varcamonti M; Soriente A
Eur J Med Chem; 2013 Nov; 69():779-85. PubMed ID: 24099997
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and structure-activity relationship of 7-(substituted)-aminomethyl-4-quinolone-3-carboxylic acid derivatives.
Zhang Z; Yu A; Zhou W
Bioorg Med Chem; 2007 Dec; 15(23):7274-80. PubMed ID: 17826097
[TBL] [Abstract][Full Text] [Related]
60. Synthesis, in vitro antibacterial activities of a series of 3-N-substituted canthin-6-ones.
Dai JK; Dan WJ; Li N; Du HT; Zhang JW; Wang JR
Bioorg Med Chem Lett; 2016 Jan; 26(2):580-583. PubMed ID: 26681509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
